African Journal of Paediatric Surgery About APSON | PAPSA  
Home About us Editorial Board Current issue Search Archives Ahead Of Print Subscribe Instructions Submission Contact Login 
Users Online: 27Print this page  Email this page Bookmark this page Small font size Default font size Increase font size 
 
 


 
LETTER TO THE EDITOR Table of Contents   
Year : 2015  |  Volume : 12  |  Issue : 3  |  Page : 208
Wilms' tumour and chemotherapeutic access


1 KMT Primary Care Center, Bangkok, Thailand
2 Faculty of Medicine, University of Nis, Nis, Serbia; Joseph Ayo Babalola University, Nigeria; Hainan Medical University, Haikou, China; Dr. D. Y. Patil Medical University, Pune, Maharashtra, India

Click here for correspondence address and email

Date of Web Publication23-Nov-2015
 

How to cite this article:
Yasri S, Wiwanitkit V. Wilms' tumour and chemotherapeutic access. Afr J Paediatr Surg 2015;12:208

How to cite this URL:
Yasri S, Wiwanitkit V. Wilms' tumour and chemotherapeutic access. Afr J Paediatr Surg [serial online] 2015 [cited 2019 Aug 20];12:208. Available from: http://www.afrjpaedsurg.org/text.asp?2015/12/3/208/170232
Sir,

We enjoy reading the recent report on 'Wilms' tumour and chemotherapeutic access'. [1] Anyanwa et al. reported that 'an institutionalised approach can help to improve access to anti-cancer drugs, reduce the rate of loss to follow-up and thus improve outcome'. [1] In fact, the problem of anticancer drug access can be seen in many developing countries. In a previous report by Uba and Chirdan, 'poor availability of cytotoxic drugs' is an important factor contributing to the poor outcome of disease in Nigeria. [2] It is suggested that pre-operative combined chemotherapy is required for the better operative curative outcome of paediatric cases of Wilms' tumours. [3] To manage the high cost of chemotherapy, some new studies show that metronomic chemotherapy can be the hope for the management of the problem. [4]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
   References Top

1.
Anyanwa LJ, Atanda AT, Atanda JO. Wilms' tumour in African children: Can an institutional approach improve outcome? Afr J Paediatr Surg 2015;12:7-11.  Back to cited text no. 1
    
2.
Uba AF, Chirdan LB. Childhood Wilms' tumour: Prognostic factors in North Central Nigeria. West Afr J Med 2007;26:222-5.  Back to cited text no. 2
    
3.
Suryanarayan K, Marina N. Wilms' tumour. Optimal treatment strategies. Drugs 1998;56:598-605.  Back to cited text no. 3
    
4.
Fousseyni T, Diawara M, Pasquier E, André N. Children treated with metronomic chemotherapy in a low-income country: METRO-MALI-01. J Pediatr Hematol Oncol 2011;33:31-4.  Back to cited text no. 4
    

Top
Correspondence Address:
Sora Yasri
KMT Primary Care Center, Bangkok, Thailand

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0189-6725.170232

Rights and Permissions




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  
 


    References

 Article Access Statistics
    Viewed1879    
    Printed15    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal